Reginster JY, Czerwinski E, Wilk K, Borowy P, et al. Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis. Osteoporos Int 2024 Jul 23. doi: 10.1007/s00198-024-07161.
PMID: 39042292